Both in Biotechnology
Moderna vs Halozyme Therapeutics
Over the past year MRNA returned +817.1% and HALO returned +94.3%; their daily moves had a correlation of 0.21.
MRNA +817.1% HALO +94.3%Growth of $1, one year, split-adjusted
| Metric | MRNA | HALO |
|---|---|---|
| Price | $228.44 | $128.62 |
| Market cap | $91.20B | $14.60B |
| Today | +3.45% | −0.26% |
| 1 month | +12.4% | +18.8% |
| 6 months | +389.1% | +95.3% |
| Year to date | +674.6% | +91.1% |
| 1 year | +741.1% | +97.3% |
| Revenue growth (YoY) | +2.1% | +47.7% |
| Gross margin | 35.9% | 83.5% |
| Net margin | −539.3% | 47.8% |
| P/E (TTM) | — | 35.3× |
| Price / sales | 40.9× | 8.8× |
| Net cash | $4.54B | -$1.92B |
| Dividend yield | — | — |
| Volatility (60d) | 230.1% | 27.8% |
| Short % of float | 9.0% | 12.4% |
| Next earnings | Nov 6, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).